Opportunities and challanges for the personalised health industry
Preventative healthcare is gaining momentum. Amongst preventative actions, food products having certain health effects, microbiome therapeutics and digital platforms monitoring and predicting health can play an important role. Obtaining and using evidence for substantiating claimed effects and deployment of the technology in the personal health space requires processing of (sensitive) personal data. Presently, we nearly have a year of experience with the EU General Data Protection Regulation (GDPR), imposing far more detailed and prescriptive requirements upon companies in the personalised health field than in previous legislation.
Topics
A regulatory expert, a nutrition business consultant and an entrepreneur active in the microbiome space will share insights about how the various types of personalised health companies currently active in the market deal with GDPR requirements in practice. Topics will include privacy by design requirements for processing personal data concerning health, accountability requirements accommodating both client and public requests, international transfer of personal data and EU enforcement actions to date.
Speakers
- Karin Verzijden LLM, Attorney at law at Axon Lawyers
- Mariëtte Abrahams MBA RD PhD Cand, Nutrition Business Consultant and Founder Mariëtte Abrahams Consulting
- Kristofer Cook MSc MBA, CEO Carbiotix
Visit the Axon website for more information and registration.
